Left Ventricular Thrombus With COVID-19 Complication in a Patient With Dilated Cardiomyopathy

Shohei Imaeda1, Hiroki Kabata2, Yasuyuki Shiraishi1

  • 1Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.

CJC Open
|September 28, 2020
PubMed

Insights

Coronavirus disease 2019 (COVID-19) can cause arterial thrombosis, a rare complication. This case highlights a left ventricular thrombus in a COVID-19 patient with dilated cardiomyopathy, successfully treated with anticoagulation.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Thrombosis Research

Background:

  • Venous thromboembolism is a known complication of COVID-19.
  • Arterial thrombosis is less commonly reported in coronavirus disease 2019 patients.

Observation:

  • A patient with non-severe COVID-19 and dilated cardiomyopathy presented with improving clinical symptoms.
  • Despite clinical improvement, D-dimer levels progressively increased.
  • Diagnostic imaging revealed a left ventricular thrombus.

Findings:

  • The left ventricular thrombus in this COVID-19 case was successfully treated with anticoagulant therapy.
  • The patient experienced thrombus resolution and clinical recovery.
  • This case underscores the potential for rare arterial thrombotic events in COVID-19.

Implications:

  • Early diagnosis and appropriate management of left ventricular thrombus are crucial in COVID-19 patients, especially those with underlying cardiac conditions like dilated cardiomyopathy.
  • This case emphasizes the need for vigilant monitoring of thrombotic markers and diagnostic imaging in specific COVID-19 patient populations.
  • Further research into the mechanisms of arterial thrombosis in COVID-19 is warranted to improve patient outcomes.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
272
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
176
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
234
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
94
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
347
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
2.0K